A previous history of cancer doesn’t necessarily preclude treatment with antibodies against tumor necrosis factor (anti-TNF) for patients with inflammatory bowel diseases, suggests a study in Inflammatory Bowel Diseases, official journal of the Crohn’s & Colitis Foundation of America. The journal is published by Wolters Kluwer.